Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

PLoS ONE ◽

10.1371/journal.pone.0034372 ◽

2012 ◽

Vol 7 (4) ◽

pp. e34372 ◽

Author(s):

Tara L. Kieffer ◽

Sandra De Meyer ◽

Doug J. Bartels ◽

James C. Sullivan ◽

Eileen Z. Zhang ◽

...

Keyword(s):

Clinical Trials ◽

Hepatitis C ◽

Viral Evolution ◽

Treatment Naïve

Download Full-text

Direct antiviral agents for treatment-naïve patients with genotype 1 hepatitis C: A statistical model for comparing outcomes between real world and clinical trials

Digestive and Liver Disease ◽

10.1016/j.dld.2015.06.012 ◽

2015 ◽

Vol 47 (11) ◽

pp. 988-989

Author(s):

Andrea Messori ◽

Maurizia R. Brunetto ◽

Andrea De Luca ◽

Anna Linda Zignego

Keyword(s):

Clinical Trials ◽

Hepatitis C ◽

Statistical Model ◽

Antiviral Agents ◽

Treatment Naïve ◽

Direct Antiviral Agents

Download Full-text

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Download Full-text

Faculty of 1000 evaluation for Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717965604.793466618 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Randomised Clinical Trial ◽

Combination Regimen ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020296.793478787 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C ◽

Phase 2 ◽

Hepatitis C Infection ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Treatment Naïve ◽

Peginterferon Alfa ◽

Download Full-text

Faculty Opinions recommendation of Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718056251.793482742 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C ◽

Pegylated Interferon ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718196356.793490906 ◽

2014 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Low Dose ◽

Pegylated Interferon ◽

Virus Genotype ◽

Interferon Α2a ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725431366.793505980 ◽

2015 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Phase 3 ◽

Treatment Naïve ◽

Dose Combination ◽

Previously Treated

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

1170 PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES

Journal of Hepatology ◽

10.1016/s0168-8278(12)61182-9 ◽

2012 ◽

Vol 56 ◽

pp. S463

Author(s):

N. Hernandez ◽

M. Vera-Llonch ◽

J. Aggarwal ◽

M. Donepudi ◽

Z. Younossi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase 3 ◽

Treatment Naïve ◽

Post Hoc ◽

Chronic Hepatitis C Patients

Download Full-text

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

Journal of Gastroenterology ◽

10.1007/s00535-015-1120-x ◽

2015 ◽

Vol 51 (4) ◽

pp. 390-403 ◽

Author(s):

Norio Hayashi ◽

Makoto Nakamuta ◽

Tetsuo Takehara ◽

Hiromitsu Kumada ◽

Akiko Takase ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Japanese Patients ◽

Phase Iii ◽

Virus Genotype ◽

Treatment Naïve ◽

Phase Iii Study ◽

Peginterferon Alfa

Download Full-text